Marshall Urist
EVP, Research & Investments at Royalty Pharma · 21 reported transactions in 1 company · latest trade Sep 28, 2026
Their trades
Sold | Sep 28, 2026 | Sep 28, 2026 close $58.37 → Oct 29, 2026 close $65.93. S&P 500 +0.5% over the same days. | ||
Sold | Jul 1, 2026 | Jul 1, 2026 close $55.78 → Oct 29, 2026 close $65.93. S&P 500 +3.2% over the same days. | ||
Sold | Jun 24, 2026 | Jun 24, 2026 close $54.28 → Oct 29, 2026 close $65.93. S&P 500 +4.9% over the same days. | ||
Sold | May 20, 2026 | May 20, 2026 close $53.06 → Oct 29, 2026 close $65.93. S&P 500 +3.8% over the same days. | ||
Sold | Jan 30, 2026 | Jan 30, 2026 close $41.68 → Oct 29, 2026 close $65.93. S&P 500 +11.2% over the same days. | ||
Sold | Jan 23, 2026 | Jan 23, 2026 close $40.40 → Oct 29, 2026 close $65.93. S&P 500 +11.6% over the same days. | ||
Sold | Jan 16, 2026 | Jan 16, 2026 close $39.55 → Oct 29, 2026 close $65.93. S&P 500 +11.2% over the same days. | ||
Sold | Jan 9, 2026 | Jan 9, 2026 close $40.17 → Oct 29, 2026 close $65.93. S&P 500 +10.8% over the same days. |
SoldRoyalty Pharma
$238.8K
Sep 28, 2026 close $58.37 → Oct 29, 2026 close $65.93. S&P 500 +0.5% over the same days.
SoldRoyalty Pharma
$508.5K
Jul 1, 2026 close $55.78 → Oct 29, 2026 close $65.93. S&P 500 +3.2% over the same days.
SoldRoyalty Pharma
$502.1K
Jun 24, 2026 close $54.28 → Oct 29, 2026 close $65.93. S&P 500 +4.9% over the same days.
SoldRoyalty Pharma
$721.8K
May 20, 2026 close $53.06 → Oct 29, 2026 close $65.93. S&P 500 +3.8% over the same days.
SoldRoyalty Pharma
$821.8K
Jan 30, 2026 close $41.68 → Oct 29, 2026 close $65.93. S&P 500 +11.2% over the same days.
SoldRoyalty Pharma
$805.1K
Jan 23, 2026 close $40.40 → Oct 29, 2026 close $65.93. S&P 500 +11.6% over the same days.
SoldRoyalty Pharma
$790.3K
Jan 16, 2026 close $39.55 → Oct 29, 2026 close $65.93. S&P 500 +11.2% over the same days.
SoldRoyalty Pharma
$815.6K
Jan 9, 2026 close $40.17 → Oct 29, 2026 close $65.93. S&P 500 +10.8% over the same days.